Schechter Investment Advisors’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Schechter Investment Advisors’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-93,780	Closed	-$914K	–	764
2023 Q1	$914K	Hold	93,780	–	–	0.08%	273
2022 Q4	$916K	Hold	93,780	–	–	0.08%	318
2022 Q3	$924K	Hold	93,780	–	–	0.09%	306
2022 Q2	$911K	Hold	93,780	–	–	0.09%	318
2022 Q1	$916K	Sell	93,780 -1,220	-1%	-$12K	0.09%	338
2021 Q4	$927K	Buy	+95,000	New	+$945K	0.08%	332

Schechter Investment Advisors's ORIAU Position: Q2 2023 in Review

Schechter Investment Advisors sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q2 2023, closing a stake of 93,780 shares — an estimated $914K sold.

Schechter Investment Advisors first reported a position in ORIAU in Q4 2021 and held it in 6 quarters. The position peaked at $927K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAU as of Q2 2023.

Schechter Investment Advisors reported no remaining Orion Biotech Opportunities Corp. Units position as of Q2 2023 after selling out during the quarter.
Schechter Investment Advisors sold 93,780 Orion Biotech Opportunities Corp. Units shares in Q2 2023, an estimated $914K.
Schechter Investment Advisors first reported a position in Orion Biotech Opportunities Corp. Units in Q4 2021 and held it in 6 quarters.
Schechter Investment Advisors's Orion Biotech Opportunities Corp. Units position peaked at $927K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q2 2023.

Based on Schechter Investment Advisors's 13F filing for Q2 2023, filed 26 Jul 2023.